ClinAstra Insights

The ClinAstra Blog

Insights on AI-powered clinical data review, trial timeline optimization, and the future of clinical development.

Page 2 of 4

Medidata vs Veeva: Which Clinical Data Platform Actually Cuts Your Review Timeline?
Aug 11, 2026•14 min read

Medidata vs Veeva: Which Clinical Data Platform Actually Cuts Your Review Timeline?

Medidata Rave and Veeva Vault EDC both capture clinical trial data — but neither solves the manual review bottleneck. Compare them on review speed and learn how AI cuts LPLV-to-database lock from months to days.

Read more
AI Clinical Data Review: How AI Replaces Manual Review From Months to Days
Aug 10, 2026•16 min read

AI Clinical Data Review: How AI Replaces Manual Review From Months to Days

Manual clinical data review is broken. AI replaces it with 99.9% accuracy, traceable queries, and audit-ready transparency. Here's how clinical ops teams cut review timelines from months to days.

Read more
The Best Clinical Data Review Software in 2026 Isn't Software at All — It's AI That Replaces Manual Review
Aug 9, 2026•16 min read

The Best Clinical Data Review Software in 2026 Isn't Software at All — It's AI That Replaces Manual Review

The best clinical data review software in 2026 isn't another EDC dashboard — it's AI that replaces manual review with 99.9% accuracy. Compare AI-native review against Veeva, Medidata, and Oracle and see why the bottleneck is review, not science.

Read more
Automated Clinical Data Review: How AI Replaces Manual Query Management
Aug 8, 2026•14 min read

Automated Clinical Data Review: How AI Replaces Manual Query Management

Automated clinical data review replaces manual query generation, lab reconciliation, and SDTM validation with AI-native processes delivering 99.9% accuracy and audit-ready traceability. From months to days.

Read more
The Faster Drug Approval Process Doesn't Run Through the FDA — It Runs Through Data Review
Aug 7, 2026•13 min read

The Faster Drug Approval Process Doesn't Run Through the FDA — It Runs Through Data Review

The drug approval process takes 10-15 years and $1.3-2.6B — but the bottleneck isn't science or FDA review. It's manual clinical data review. Tufts CSDD puts delay costs at $500K/day. AI compresses data review from months to days at 99.9% accuracy.

Read more
Clinical Data Management Challenges: What the Industry Won't Admit (And How AI Fixes Them)
Aug 6, 2026•13 min read

Clinical Data Management Challenges: What the Industry Won't Admit (And How AI Fixes Them)

The 7 clinical data management challenges slowing trials to a crawl — and why AI replaces manual review to fix them. Built by people who lived the pain.

Read more
Clinical Trial Data Review Timeline: From Months to Days With AI
Aug 4, 2026•11 min read

Clinical Trial Data Review Timeline: From Months to Days With AI

The clinical trial data review timeline is broken — and the industry has quietly accepted the breakage as fact. While protocol design, site activation,...

Read more
SDTM Dataset Review Automation: Why AI Replaces Manual Data Review, Not Just Speeds It Up
Aug 3, 2026•14 min read

SDTM Dataset Review Automation: Why AI Replaces Manual Data Review, Not Just Speeds It Up

Manual SDTM dataset review is broken. With AI-powered review automation, clinical teams move from months to days, hit 99.9% accuracy, and free their teams for decisions - not data entry.

Read more

Review less. Decide more.

See how ClinAstra replaces manual clinical data review with AI — 99.9% accuracy, audit-ready, from months to days.

Request a Demo